Some laboratory studies have shown that GLP-1 analogs may reduce cartilage degradation and synovial inflammation in experimental arthritis models
How Is the Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Segmented
Reduces markers of systemic inflammation, which contribute to chronic disease
A study presented on June 14 at ENDO 2026, the Endocrine Societys annual meeting in Chicago, had researchers use data from the National Institutes of Healths All of Us Research Program, which links participants electronic health records with their Fitbit activity data
These gastrointestinal effects are generally mild to moderate and far less dangerous than the complications of uncontrolled diabetes, such as heart disease, kidney damage, and nerve damage
23 (5): 545-551 DOC ID 090006d180b7ff26